These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

73 related articles for article (PubMed ID: 16124113)

  • 1. Non-HIV related deaths rises to 26% in NYC. IDUs had highest mortality rate.
    AIDS Alert; 2005 Aug; 20(8):90-1. PubMed ID: 16124113
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Excess mortality among injection drug users with AIDS, New York City (1999-2004).
    Pfeiffer MR; Hanna DB; Begier EM; Sepkowitz KA; Zimmerman R; Sackoff JE
    Subst Use Misuse; 2011; 46(2-3):245-53. PubMed ID: 21303244
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A multicentre study on the causes of death among Italian injecting drug users. AIDS has overtaken overdose as the principal cause of death.
    Mezzelani P; Quaglio GL; Venturini L; Lugoboni F; Friedman SR; Des Jarlais DC
    AIDS Care; 1998 Feb; 10(1):61-7. PubMed ID: 9536202
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The shifting pattern of cause-specific mortality in a cohort of human immunodeficiency virus-infected and non-infected injecting drug users.
    Ferreros I; Lumbreras B; Hurtado I; Pérez-Hoyos S; Hernández-Aguado I
    Addiction; 2008 Apr; 103(4):651-9. PubMed ID: 18339110
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Death, AIDS morbidity, and HIV seroprevalence in New York City intravenous drug abusers.
    Burkett W; Brown LS
    J Natl Med Assoc; 1990 Nov; 82(11):777-80. PubMed ID: 2258951
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of education on overall and cause-specific mortality in injecting drug users, according to HIV and introduction of HAART.
    Jarrin I; Lumbreras B; Ferreros I; Pérez-Hoyos S; Hurtado I; Hernández-Aguado I
    Int J Epidemiol; 2007 Feb; 36(1):187-94. PubMed ID: 17085455
    [TBL] [Abstract][Full Text] [Related]  

  • 7. AIDS deaths are falling sharply.
    Fam Plann Perspect; 1998; 30(2):54. PubMed ID: 9561868
    [No Abstract]   [Full Text] [Related]  

  • 8. Predictors of mortality among injecting and non-injecting HIV-negative drug users in northern Thailand.
    Quan VM; Vongchak T; Jittiwutikarn J; Kawichai S; Srirak N; Wiboonnatakul K; Razak MH; Suriyanon V; Celentano DD
    Addiction; 2007 Mar; 102(3):441-6. PubMed ID: 17298652
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Population prevalence of reported and unreported HIV and related behaviors among the household adult population in New York City, 2004.
    Nguyen TQ; Gwynn RC; Kellerman SE; Begier E; Garg RK; Pfeiffer MR; Konty KJ; Torian L; Frieden TR; Thorpe LE
    AIDS; 2008 Jan; 22(2):281-7. PubMed ID: 18097231
    [TBL] [Abstract][Full Text] [Related]  

  • 10. NYC reports sharp decline in AIDS deaths.
    Minn Med; 1997 Mar; 80(3):55. PubMed ID: 9090252
    [No Abstract]   [Full Text] [Related]  

  • 11. New York City injection drug users' memories of syringe-sharing patterns and changes during the peak of the HIV/AIDS epidemic.
    Rockwell R; Joseph H; Friedman SR
    AIDS Behav; 2006 Nov; 10(6):691-8. PubMed ID: 16708274
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Trend of mortality observed in a cohort of drug addicts of the metropolitan area of Bologna, North-Eastern Italy, during a 25-year-period.
    Manfredi R; Sabbatani S; Agostini D
    Coll Antropol; 2006 Sep; 30(3):479-88. PubMed ID: 17058511
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Same-sex attraction disclosure to health care providers among New York City men who have sex with men: implications for HIV testing approaches.
    Bernstein KT; Liu KL; Begier EM; Koblin B; Karpati A; Murrill C
    Arch Intern Med; 2008 Jul; 168(13):1458-64. PubMed ID: 18625927
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Integrating multiple programme and policy approaches to hepatitis C prevention and care for injection drug users: a comprehensive approach.
    Birkhead GS; Klein SJ; Candelas AR; O'Connell DA; Rothman JR; Feldman IS; Tsui DS; Cotroneo RA; Flanigan CA
    Int J Drug Policy; 2007 Oct; 18(5):417-25. PubMed ID: 17854731
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Estimating the total mortality among problem drug users.
    Cruts G; Buster M; Vicente J; Deerenberg I; Van Laar M
    Subst Use Misuse; 2008; 43(5):733-47. PubMed ID: 18393087
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Adult AIDS in New York City--risk categories.
    Chiasson MA
    Bull N Y Acad Med; 1995; 72(2):538-9. PubMed ID: 10101388
    [No Abstract]   [Full Text] [Related]  

  • 17. Declining AIDS mortality in New York City. New York City Department of Health.
    Chiasson MA
    Bull N Y Acad Med; 1997; 74(1):151-2. PubMed ID: 9211010
    [No Abstract]   [Full Text] [Related]  

  • 18. Harm reduction interventions, behaviours and associated health outcomes in France, 1996-2003.
    Emmanuelli J; Desenclos JC
    Addiction; 2005 Nov; 100(11):1690-700. PubMed ID: 16277629
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mortality among injecting drug users in Melbourne: a 16-year follow-up of the Victorian Injecting Cohort Study (VICS).
    Stoové MA; Dietze PM; Aitken CK; Jolley D
    Drug Alcohol Depend; 2008 Aug; 96(3):281-5. PubMed ID: 18434044
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Investigation of a new diagnosis of multidrug-resistant, dual-tropic HIV-1 infection--New York City, 2005.
    Centers for Disease Control and Prevention (CDC)
    MMWR Morb Mortal Wkly Rep; 2006 Jul; 55(29):793-6. PubMed ID: 16874293
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.